-+ 0.00%
-+ 0.00%
-+ 0.00%

Eikon Therapeutics Set To Join Russell 3000 Index, Effective June

Benzinga·06/25/2026 20:15:55
Listen to the news

Eikon Therapeutics, Inc. (NASDAQ:EIKN) ("Eikon"), a late-stage clinical biopharmaceutical company dedicated to developing innovative medicines to address serious unmet medical needs, today announced that it will be added to the broad-market Russell 3000® Index following the annual reconstitution, effective after the US market closes on June 26, 2026.